//
Ben And Catherine Ivy Foundation is a private corporation based in SCOTTSDALE, AZ. The foundation received its IRS ruling in 2011. It holds total assets of $299.8M. Annual income is reported at $38.8M. The foundation operates in the area of philanthropy & grantmaking. According to available records, Ben And Catherine Ivy Foundation has made 62 grants totaling $32.5M, with a median grant of $250K. Individual grants have ranged from $150 to $5.5M, with an average award of $542K. The foundation has supported 26 unique organizations. The foundation primarily supports organizations in Arizona, Minnesota, Texas, which account for 55% of all grants. Grantmaking reaches organizations across 12 states. Contributions to this foundation are tax-deductible.
Ben And Catherine Ivy Foundation primarily funds organizations in the area of philanthropy & grantmaking. Based on available records, the foundation has funded 62 grants. Its grantmaking reaches organizations primarily in AZ, MN, TX.
Ben And Catherine Ivy Foundation has distributed a total of $32.5M across 62 grants. The median grant size is $250K, with an average of $542K. Individual grants have ranged from $150 to $5.5M.
Ben And Catherine Ivy Foundation typically selects its grantees rather than accepting unsolicited proposals.
Ben And Catherine Ivy Foundation is headquartered in SCOTTSDALE, AZ. While based in AZ, the foundation distributes grants to organizations across 12 states.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Catherine E Ivy | President | $383K | $13K | $397K |
| Megan Edwards | Treasurer | $0 | $0 | $0 |
| Stephanie Mcrae Esq | Secretary | $0 | $0 | $0 |
Total Giving
$16.6M
Total Assets
$293.3M
Fair Market Value
$333.2M
Net Worth
$293.3M
Grants Paid
$14.8M
Contributions
$540
Net Investment Income
$12.9M
Distribution Amount
$15.5M
Total: $55K
Total Grants
62
Total Giving
$32.5M
Average Grant
$542K
Median Grant
$250K
Unique Recipients
26
Most Common Grant
$300K
| Recipient | Location | Amount | Year |
|---|---|---|---|
| Society Of St Vincent De PaulCENTER FOR FAMILY WELLNESS ESTABLISHED TO FOCUS ON THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES THROUGH NUTRITION, PHYSICAL ACTIVITY AND OVERALL WELLNESS. ITS CULTURALLY GROUNDED BILINGUAL EDUCATION PROGRAMS ENCOURAGE THE WHOLE FAMILY TO PARTICIPATE. PAYMENT #3. | Phoenix, AZ | $250K | 2022 |
| Neurotrials LlcPREPAYMENT OF 2023 CEREBROSPINAL FLUID ANALYSIS. | Phoenix, AZ | $5.5M | 2022 |
| Neuro Trials LlcIVY BRAIN TUMOR CENTER BUILDING EXPANSION SPECIAL GRANT AMENDMENT. | Phoenix, AZ | $5M | 2022 |
| H Lee Moffitt Cancer CenterIN EXAMINING THE ROLE OF TUMORS CELLS IN MODULATING BONE MARROW-DERIVED MACROPHAGES AND MICROGLIA, THIS STUDY SEEKS TO TAILOR NOVEL THERAPEUTICS FOR TARGETING OF TUMOR ASSOCIATED MACROPHAGES. PAYMENT 2 OF 2. | Rochester, MN |
| $300K |
| 2022 |
| University Of Tx Md Anderson CancerPROJECT SEEKS TO PRECLINICALLY OPTIMIZE NOVEL THERAPEUTIC APPROACHES FOR ATRX-DEFICIENT MALIGNANT GLIOMAS TARGETING G-QUADRUPLEX DNA SECONDARY STRUCTURE. PAYMENT 1 OF 2. | Houston, TX | $300K | 2022 |
| University Of MichiganNEW METHODS WILL BE DEVELOPED TO MEASURE THE ACTIVITY OF TUMOR METABOLIC PATHWAYS IN PATIENTS WITH GLIOBLASTOMA AND TO DETERMINE WHETHER DRUGS DESIGNED TO BLOCK THESE PATHWAYS ARE SUITABLE. PAYMENT 2 OF 2. | Ann Arbor, MI | $300K | 2022 |
| Univ Of New Mexico Health SciencesIDENTIFY MECHANISMS UNDERLYING INFLAMMATORY CELL CONTRIBUTION TO THE EMERGENCE OF THE RECURRENT TUMOR BY SINGLE-CELL ANALYSIS OF RESIDUAL DISEASE IN GLIOBLASTOMA PATIENTS. PAYMENT 2 OF 2. | Albuquerque, NM | $300K | 2022 |
| Univ Of Miami Miller School Of MediUSING PATIENT DERIVED ORTHOTOPIC XENOGRAFT MODELS AND A NOVEL IMMUNOCOMPETENT MODEL OF GBM, THE EFFICACY OF A MTl-MMP INHIBITOR IN COMBINATION WITH RADIATION/TMZ WILL BE TESTED TO DETERMINE ITS EFFECTS ON THE IMMUNE COMPONENT OF THE TUMOR MICROENVIRONMENT. PAYMENT 2 OF 2. | Miami, FL | $300K | 2022 |
| Yale Cancer CenterUSE OF A NOVEL TRANSFORMATIONAL PLATFORM FOR RAPID IDENTIFICATION OF TARGETS AND TREATMENTS TO INHIBIT GROWTH AND INVASION OF GLIOBLASTOMA CELLS BASED ON RAPID PATIENT SAMPLE SCREENING USING NOVEL NANO-ENGINEERING TECHNIQUES. PAYMENT 2 OF 2. | New Haven, CT | $300K | 2022 |
| Mayo Clinic College Of MedicineEVALUATE CANDIDATE GLIOMA CSF PROTEOMIC SIGNATURES TO HELP UNDERSTAND AND MONITOR GLIOMA EVOLUTION IN LIVING PATIENTS DURING STANDARD OF CARE AND EXPERIMENTAL IMMUNOTHERAPY. PAYMENT 1 OF 2. | Rochester, MN | $300K | 2022 |
| Swedish Medical CenterASSESS COMBINATIONS OF SMALL MOLECULES AND IMMUNOTHERAPIES FOR KILLING GLIOBLASTOMA TUMOR CELLS IN A PERSONALIZED EX VIVO ECOSYSTEM WITH INTACT TUMOR MICROENVIRONMENT USING MULTIPLEX IMMUNOCHEMISTRY AND SPATIAL MAPPING OF CELL TYPES. PAYMENT 1 OF 2. | Seattle, WA | $300K | 2022 |
| Uc San DiegoSMALL MOLECULE REGULATION OF REST PROTEIN LEVELS PROVIDES AN IDEAL PLATFORM FOR DEVELOPING A NEW THERAPEUTIC FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME. PAYMENT 1 OF 2. | La Jolla, CA | $300K | 2022 |
| Memorial Sloan Kettering Cancer CenDISCOVER AND DESCRIBE DORMANT TUMOR CELLS CALLED CANCER STEM CELLS THAT RESIDE WITHIN ADULT GLIOMA AND ARE RESISTANT TO CURRENT THERAPIES. PAYMENT 1 OF 2. | New York, NY | $300K | 2022 |
| Mayo ClinicIDENTIFY THE ONCOGENIC SIGNALING DEPENDENCIES THAT CHARACTERIZE EACH OF THE CELLULAR SUBPOPULATIONS THAT COMPRISE A GLIOBLASTOMA TUMOR, AND FROM THIS INFORMATION CONSTRUCT A NON-TOXIC COMBINATION OF KINASE INHIBITORS TO EFFECTIVELY TREAT THIS DISEASE. PAYMENT 1 OF 2. | Jacksonville, FL | $269K | 2022 |
| Virginia TechTO INHIBIT TUMOR CELL INVASION AND INVASION, TARGETED THERAPEUTICS WILL BE COUPLED TO BIOMARKER-BASED IMAGING IN PATIENT-SPECIFIC MODELS OF GLIOBLASTOMA. PAYMENT 2 OF 2. | Roanoke, VA | $250K | 2022 |
| Vanderbilt UniversityUSING SINGLE-CELL AND SYSTEMS BIOLOGY APPROACHES IN GLIOBLASTOMA, CELL SUBTYPES WILL BE MAPPED TO GLIOBLASTOMA TISSUES AND EXPERIMENTAL MODELS, ENABLING IDENTIFICATION AND PRECLINICAL TARGETING OF INTERACTIONS BETWEEN CANCER CELLS, IMMUNE CELLS, AND LOCATION SPECIFIC RESIDENT BRAIN CELLS. PAYMENT 2 OF 2. | Nashville, TN | $250K | 2022 |
| Columbia University Irving MedicalTARGETING THE GLIOBLASTOMA MASTER REGULATOR CEBP A PHARMACOKINETICS AND PHARMACODYNAMICS SURGICAL STUDY OF ST101. PAYMENT 1 OF 2. | New York, NY | $250K | 2022 |
| Ut Southwestern Medical CenterPRECLINICAL INVESTIGATION OF FOCUS ULTRASOUND GUIDED DELIVERY TO FACILITATE A LIPOPROTEIN-OMEGA-3 FATTY ACID-BASED BIOLOGICAL THERAPY IN GLIOBLASTOMA. PAYMENT 2 OF 2. | Dallas, TX | $210K | 2022 |
| Damon Runyon Cancer Research FdnINVESTIGATION OF A BIOMARKER PHASE 2 STUDY TO EVALUATE TARGETED THERAPY HARBORING SPECIFIC GENETIC ALTERATIONS. PAYMENT 3 | New York, NY | $120K | 2022 |
| Translational Genomics Research TgeNEUROLOGICAL SCIENCES INTERNSHIP PROGRAM AT TGEN DESIGNED TO GIVE HIGH SCHOOL AND UNDERGRADUATE STUDENTS INTENSIVE, HANDS-ON RESEARCH EXPERIENCE WORKING ALONGSIDE A MENTOR-SCIENTIST TO LEARN ABOUT TRANSLATIONAL RESEARCH WHILE INVESTIGATING QUESTIONS WITHIN NEUROLOGICAL SCIENCES. | Phoenix, AZ | $78K | 2022 |
| Arcs FoundationADVANCE SCIENCE AND TECHNOLOGY IN THE UNITED STATES BY PROVIDING AWARDS TO ACADEMICALLY OUTSTANDING US CITIZENS STUDYING TO COMPLETE DEGREES IN SCIENCE, ENGINEERING AND MEDICAL RESEARCH. | Artesia, CA | $9K | 2022 |
| Barrow Neurological FdnPROVIDES PHILANTHROPIC SUPPORT FOR BARROW NEUROLOGICAL INSTITUTE AT ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER. BARROW IS AN INTERNATIONAL LEADER IN THE TREATMENT, RESEARCH, AND EDUCATION OF BRAIN AND SPINAL DISEASES, CONDITIONS AND INJURIES. | Phoenix, AZ | $5K | 2022 |
| NotmykidLIFESAVING PROGRAMS, SUPPORT, RESOURCES, AND EDUCATION TO EMPOWER ADN EDUCATE YOUTH, FAMILES, AND COMMUNITIES WITH THE KNOWLEDGE AND COURAGE TO IDENTIFY AND PREVENT NEGATIVE YOUTH BEHAVIOR. | Scottsdale, AZ | $1K | 2022 |
| Amanda Hope RainbowBRINGING DIGNITY AND COMFORT INTO THE HARSH WORLD OF CHILDHOOD CANCER AND OTHER THREATENING DISEASES. | Phoenix, AZ | $500 | 2022 |
| O'Connor InstituteADVANCES SANDRA DAY O'CONNOR'S DISTINGUISHED LEGACY AND LIFETIME WORK TO ADVANCE CIVICS EDUCATION, CIVIC ENGAGEMENT AND CIVIL DISCOURSE. | Phoenix, AZ | $500 | 2022 |
| Lung Cancer Research FoundationIMPROVES LUNG CANCER OUTCOMES BY FUNDING RESEARCH FOR THE PREVENTION, DIAGNOSIS, TREATMENT AND CURE OF LUNG CANCER. | New York, NY | $150 | 2022 |
© 2026 Granted AI